Vertex Pharmaceuticals (VRTX) Misses Q4 Earnings Estimates
Portfolio Pulse from
Vertex Pharmaceuticals (VRTX) reported Q4 earnings of $3.98 per share, slightly missing the Zacks Consensus Estimate of $3.99. This is a decrease from $4.20 per share a year ago.
February 10, 2025 | 11:30 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Vertex Pharmaceuticals reported Q4 earnings of $3.98 per share, missing the estimate of $3.99 and down from $4.20 last year.
The slight miss in earnings per share compared to estimates and the year-over-year decline could lead to short-term negative sentiment among investors, potentially putting downward pressure on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100